Structured evidence table for Spirulina Cardiometabolic Markers Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Spirulina Cardiometabolic Markers Meta-Analysis | Results: Spirulina supplementation reduced infarct size by 64%, increased myocardial salvage by 18%, and improved cardiac function by 30% vs. | 4 | Vilahur G (2022) | Supplementation With Spirulina Reduces Infarct Size and Ameliorates Cardiac Function in a Pig Model of STEMI. |
| Spirulina Cardiometabolic Markers Meta-Analysis | controls ( p p Conclusion: A 10-day supplementation with spirulina exerts cardioprotection in a preclinical setting of STEMI by limiting cardiac damage and improving ventricular contractility through anti-oxidative, anti-inflammatory, and anti-apoptotic mechanisms. | 4 | Vilahur G (2022) | Supplementation With Spirulina Reduces Infarct Size and Ameliorates Cardiac Function in a Pig Model of STEMI. |
| Spirulina Cardiometabolic Markers Meta-Analysis | Background and Aims: Myocardial infarction (MI) is the clinical manifestation of atherosclerotic coronary artery disease. | 4 | Vilahur G (2022) | Supplementation With Spirulina Reduces Infarct Size and Ameliorates Cardiac Function in a Pig Model of STEMI. |
| Spirulina Cardiometabolic Markers Meta-Analysis | Spirulina is an algae known to ameliorate cardiometabolic disorders and with proven anti-inflammatory and anti-oxidant effects. | 4 | Vilahur G (2022) | Supplementation With Spirulina Reduces Infarct Size and Ameliorates Cardiac Function in a Pig Model of STEMI. |
| Spirulina Cardiometabolic Markers Meta-Analysis | It is associated with underlying low-grade inflammation, thus is a risk factor for the development of cardiometabolic alterations. | 4 | Gómez-Téllez A (2020) | Effects of a Low-Dose Spirulina/Turmeric Supplement on Cardiometabolic and Antioxidant Serum Markers of Patients With Abdominal Obesity. |
| Spirulina Cardiometabolic Markers Meta-Analysis | After 3-month supplementation (altogether with individualized dietary management), both groups showed a decrease in body weight, fat mass, and abdominal circumference; however, no intergroup statistical differences were found. | 4 | Gómez-Téllez A (2020) | Effects of a Low-Dose Spirulina/Turmeric Supplement on Cardiometabolic and Antioxidant Serum Markers of Patients With Abdominal Obesity. |
| Spirulina Cardiometabolic Markers Meta-Analysis | Finally, both groups significantly increased their serum antioxidant status, although the supplemented groups showed a two-fold accrue vs. | 4 | Gómez-Téllez A (2020) | Effects of a Low-Dose Spirulina/Turmeric Supplement on Cardiometabolic and Antioxidant Serum Markers of Patients With Abdominal Obesity. |
| Spirulina Cardiometabolic Markers Meta-Analysis | Functional foods, such as spirulina and turmeric, in the form of nutraceutics have been considered to exert not only an antioxidant effect but also modulate mechanisms in the metabolic pathways underlying cardiometabolic disruptions. | 4 | Gómez-Téllez A (2020) | Effects of a Low-Dose Spirulina/Turmeric Supplement on Cardiometabolic and Antioxidant Serum Markers of Patients With Abdominal Obesity. |
Source documents